Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(15 sites)

China

The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui

Guangdong Provincial People's Hospital, Guangzhou, Guangdong

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Nanjing First Hospital Nanjing Medical University, Nanjing, Jiangsu

Subei People's Hospital of Jiangsu Province, Yangzhou, Jiangsu

Qilu Hospital of Shandong University, Jinan, Shandong

West China Hospital of Sichuan University, Chengdu, Sichuan

The Friendship Hospital of Yili Kazak Autonomous Prefecture, Kazak, Xinjiang

The Seventh Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang

The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan

Beijing Anzhen Hospital Capital Medical University, Beijing

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

The Second Affiliated Hospital of Nanchang University, Nanchang

Shanghai East Hospital Tongji University, Shanghai

TEDA International Cardiovascular Hospital, Tianjin